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1. Introduction 
-1,3-Galactosyltransferase (-GalT) is a key enzyme in mediating the synthesis of the 
Gal1-3Gal (-Gal) epitope on the cell surface of some mammalian species. Removal of the 
epitope is considered a prerequisite for xenotransplantation (Cooper et al., 1994). Thus, the 
production of genetically modified (GM) pigs that lack the expression of the -Gal epitope 
has been the main target for pig-to-human xenotransplantation, and this can be performed 
by somatic cell nuclear transfer (SCNT) of porcine cells lacking -GalT messenger RNA 
(mRNA) synthesis obtained by gene targeting (Lai et al., 2002; Dai et al., 2002; Phelps et al., 
2003; Ramsoondar et al., 2003; Harrison et al., 2004; Kolber-Simonds et al., 2004; Takahagi et 
al., 2005). However, this approach is labor-intensive and time-consuming, and sometimes it 
is difficult to obtain knockout (KO) pigs. Other methods of genetically modifying pigs to 
obtain reduced levels of -Gal epitope have been reported. One involves the production of 
cells/piglets overexpressing Clostridium perfringens-derived endo--galacosidase C 
(EndoGalC), which is capable of digesting -Gal epitope (Yazaki et al., 2009; Himaki et al., 
2010), and the other involves the production of cells/blastocysts overexpressing small 
interference RNA (siRNA) targeted to -GalT mRNA (Yu et al., 2005; Zhu et al., 2005; Chi et 
al., 2010). Recently, zinc finger nuclease-mediated destruction of the endogenous -GalT 
gene was reported by Hauschilda et al. (2011). In any case, however, for SCNT-mediated 
transgenesis, acquisition of a population of pure GM cells is a prerequisite because 
contamination of nontransfected cells or cells with low transgene expression would decrease 
the SCNT efficiency. Historically, cytotoxicity-based selection of -Gal epitope-negative cells 
was first used for selection of cells completely lacking expression of -GalT mRNA (Sharma 
et al., 2003). This can be performed by using specific antibodies (monoclonal antibodies) 
recognizing the -Gal epitope and complement. Kolber-Simonds et al. (2004) used anti--
Gal epitope antibodies from naive baboon plasma (natural antibodies) and baby rabbit 
complement. Baumann et al. (2004) also used a method similar to that of Kolber-Simonds et 
al. (2004). Although these cytotoxicity-based methods appear to be simple and convenient, it 
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is often difficult to obtain -Gal epitope-specific antibodies using these methods, and the 
strength of complement is sometimes variable, depending on the quality used. Fujimura et 
al. (2008) used magnet-activated cell sorting in the selection of -Gal epitope-negative cells. 
This selection process successfully eliminates -Gal epitope-positive cells by using biotin-
labeled Bandeiraea simplicifolia isolectin-B4 (IB4), a lectin that specifically binds to -Gal 
epitope (Vaughan et al., 1994). However, in this case, contamination by a small number of -
Gal epitope-positive cells often occurs in the eluent after passage through the streptoavidin-
conjugated column. Thus, Phelps et al. (2003) used a bacterial toxin, Clostridium difficile toxin 
A, which binds with high affinity to -Gal epitope, to obtain -GalT-deficient pig cells. This 
method appears very simple and easy to perform, except that the reagent itself is not always 
available, limiting its use. 
We have recently proposed another approach for the elimination of -Gal epitope-positive 
cells. This approach is called targeted toxin technology (http://www.ATSbio.com), with 
which -Gal epitope-expressing cells can be efficiently eliminated by incubation of target 
cells in the presence of toxin-labeled IB4. This selection procedure is rapid and simple 
because -Gal epitope-expressing porcine cells are rapidly removed after incubation with 
toxin-labeled IB4 for 1–2 h at 37C and subsequent cultivation in normal medium for more 
than 10 days, as will be described later in more detail. 
Targeted toxins consist of the ribosome-inactivating protein saporin (Stirpe et al., 1992), 
which is conjugated to a target molecule that recognizes a cell-specific marker. When the 
conjugate is administered to cells of interest, it binds to the target cells and is absorbed, 
releasing saporin, which inactivates ribosomes. Cells not expressing the target molecule do 
not bind or absorb the conjugate, and are not affected. This can be performed simply by co-
incubating target cells with the targeted toxins for a short period before culture in normal 
conditions, as described previously. It does not require additional treatment, such as that 
with a complement to kill target cells, and the targeted toxins themselves are commercially 
available from Advanced Targeting Systems Inc. (San Diego, CA, USA). When the targeted 
toxin is not available, it is possible to form a complex between saporin and the molecule of 
interest (which must be expressed on the cell surface) by hand. In this context, targeted toxins 
are useful as a powerful tool for removing unwanted cells from a pool of GM cells. In fact, 
negative selection using targeted toxins has already been proven useful in vivo (Wiley and 
Kline, 2000; Vulchanova et al., 2001; Tarpley et al., 2004) and in vitro (Akasaka et al., 2010). 
In our previous experiments (Akasaka et al., 2010), we demonstrated that porcine embryonic 
fibroblasts (PEFs) expressing the EndoGalC gene strongly can survive after treatment with 
IB4 conjugated with saporin (hereafter referred to as IB4-SAP), but those that do so weakly 
or not at all died within 3 or 4 days after the treatment. When the surviving cells were 
inspected for possible expression of -Gal epitope on their cell surface using fluorescence-
labeled IB4, no distinct fluorescence was noted, indicating the success of the targeted toxin 
technology. 
2. Results and perspective 
In this review, we demonstrate another successful attempt performed in our laboratory of 
enriching porcine cells with highly reduced amounts of -Gal epitope. First, the PEFs were 
transfected with the siRNA expression vector pPNER5 (Fig. 1A), which carries enhanced 
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green fluorescent protein (EGFP) cDNA and neomycin resistance gene (neo) expression 
units, together with an siRNA fragment targeted to the middle region of -GalT mRNA (Chi 
et al., in press). We expected that the PEFs stably transfected with the pPNER5 plasmid 
would exhibit EGFP-derived fluorescence but decreased the expression of -Gal epitope on 
their cell surface. Staining of transfected cells cultured for 10 days without drug selection 
with Alexa Fluor 594 (red fluorescence)-labeled IB4 revealed that approximately 64% of 
fluorescent cells (132 cells counted in total) were less distinctly stained with lectin (arrows in 
Fig. 1D-a–c). The image analysis of these cells demonstrated 60–95% reduction in the level of 
-Gal epitope expressed in the normal cells. However, the remaining fluorescent cells were 
distinctly stained with lectin (arrowheads in Fig. 1D-d–f), suggesting silencing or low levels 
of siRNA expression from the integrated pPNER5 plasmid. To eliminate these fluorescent 
cells (but still expressing the -Gal epitope) and nonfluorescent cells (probably 
nontransfected cells), the cells were treated with IB4-SAP (1  106 cells; 10 days after 
transfection). Inspection of the cells 1 day after the treatment revealed massive cell death in 
the IB4-SAP-treated group (Fig. 1C-a) but not in the control group (SAP alone; Fig. 1C-b), 
indicating the effectiveness of IB4-SAP in killing -Gal epitope-expressing cells. Four days 
after the IB4-SAP treatment, the cells were passaged from a 30-mm dish onto a 60-mm dish 
and cultured in the absence of a selection drug for approximately 2 weeks. The number of 
colonies generated ranged 1–5. These colonies were next picked up by a paper method 
(Nakayama et al., 2007) and propagated systematically. Of the 3 colonies tested, all exhibited 
bright green fluorescence but reduced levels of -Gal epitope expression on their cell 
surface, as evidenced by the staining with Alexa Fluor 594-labeled IB4 (Fig. 1D-g–i). We next 
performed SCNT using the IB4-SAP-treated pPNER5 transfectants. Out of 154 enucleated 
oocytes reconstituted with pPNER5-PEFs, the developing blastocysts exhibited bright green 
fluorescence around an embryo (Fig. 2A-b, e), suggesting success of the SCNT. Staining the 
blastocyst derived from the SCNT of the pPNER5-PEFs with Alexa Fluor 594-labeled IB4 
demonstrated a great decrease in fluorescence on its cell surface (Fig. 2A-c). This was in 
contrast with the blastocyst derived from the SCNT of the pEGFP-N1-PEFs (Nakayama et 
al., 2007), which exhibited extensive staining with lectin (Fig. 2A-f). Reverse transcription-
polymerase chain reaction (RT-PCR) analysis demonstrated that all of the tested samples 
(5/5 tested) exhibited complete loss of the target 586-base pair (bp) band corresponding to 
the endogenous -GalT mRNA (lanes 1–5 in Fig. 2B). In contrast, all (2/2 tested) of the 
SCNT blastocysts derived from eggs reconstituted with pEGFP-N1-PEF nuclei exhibited a 
clear band of 586 bp (lanes 8 and 9 in Fig. 2B). These data indicate the effectiveness of RNA 
interference (RNAi) in the SCNT-derived porcine embryos and suggest the usefulness of 
IB4-SAP for enrichment of porcine cells with highly reduced levels of -Gal epitope prior to 
SCNT-mediated production of GM piglets suitable for pig-to-human xenotransplantation. 
Our major concern is how long this RNAi-mediated suppression of endogenous -GalT 
mRNA will continue beyond the blastocyst stage. Therefore, it is required to transfer the SCNT 
blastocysts into recipients for obtaining cloned GM fetuses or animals that have been carried to 
term in which reduced levels of -Gal epitope expression are expected to be maintained. 
In conclusion, we demonstrate the usefulness of targeted toxin technology here, using IB4-
SAP for enriching GM porcine cells in which -Gal epitope synthesis is almost suppressed. 
These enriched cells are useful for cell transplantation or for SCNT-mediated generation of 
GM pigs that are optimized for xenotransplantation. 
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Fig. 1. A. Plasmid pPNER5 constructed by inserting a siRNA expression unit (comprising 
hU6p and siR5) upstream of the cytomegalovirus promoter (CMVp) in pEGFP-N1 plasmid. 
Abbreviations: EGFP, enhanced green fluorescent protein cDNA; neo, neomycin resistance 
gene; siR5, siRNA targeted to -GalT mRNA; SV40 early, SV40 enhancer and early promoter; 
hU6p, human U6 promoter. B. EGFP expression in pPNER5-transfected PEFs cultured in 
G418-free PEF medium for 10 days after transfection. Approximately 10% of the cells were 
observed to express EGFP-derived green fluorescence. Bar = 25 m. C. Cells 1 day after 
treatment with pPNER5-PEFs with IB4-SAP (a) or control SAP alone (b). Before dish-washing, 
a number of floating cells are visible in the IB4-SAP-treated dish (a) but almost none in the 
control dish (b). Bar = 25 m. D. Cytochemical staining with IB4 lectin. a–f, Cells 10 days after 
transfection with linearized pPNER5 plasmid stained with Alexa Fluor 594-labeled IB4 lectin. 
Note that the fluorescent cells exhibit a mosaic pattern for lectin staining, indicating a mixture 
of cells expressing (indicated by arrowheads in d–f), not expressing, or weakly expressing -
Gal epitope (indicated by arrows in a–c). In contrast, untransfected nonfluorescent PEFs 
exhibit strong red fluorescence on the cell surface (denoted by quadrants in a–c). g–i, Cells 
surviving for 1 month after IB4-SAP treatment were examined for the presence of -Gal 
epitope on their surfaces by Alexa Fluor 594-labeled IB4. As expected, almost all the cells 
treated with IB4-SAP were slightly or not at all stained with lectin. Phase, microphotographs 
taken under light; UV, microphotographs taken under UV + light. Bar = 25 m. 
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Fig. 2. A. a–c, Reduced expression of -Gal epitope in blastocysts derived from oocytes 
reconstituted with the pPNER5-PEFs. Developing SCNT blastocysts were stained with 
Alexa Fluor 594-labeled IB4 before observation using a fluorescence microscope. Note the 
bright green fluorescence around the whole embryo (b) but marked reduction in red 
fluorescence on its cell surface (c). d–f, Control blastocyst derived from the oocytes 
reconstituted with the control pEGFP-N1-PEFs. Note the bright green (e) and red (f) 
fluorescence around the embryo. Phase, microphotographs taken under light; UV, 
microphotographs taken under UV + light. Scale bar = 50 m. B. RT-PCR analysis of 
endogenous -GalT and -actin mRNA in blastocysts derived from oocytes reconstituted 
with pPNER5-PEFs. Lanes 1–5, Blastocysts derived from oocytes reconstituted with 
pPNER5-transfected PEFs; lane 6, water subjected to RT-PCR (negative control); lane 7, PEFs 
(positive control); lanes 8 and 9, blastocysts derived from oocytes reconstituted with control 
pEGFP-N1-PEFs.  
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